With hyper- and sustaining-activation in over 70% of human cancers, STAT3 is widely considered as an oncogene and therapeutic target in various types of cancers, and a series of chemicals or targeted biomacromolecules have been employed in clinical cancer treatment. The gene discussed is STAT3; the disease is cancer.